🇺🇸 FDA
Patent

US 9447406

Chemically modified cystathionine beta-synthase enzyme for treatment of homocystinuria

granted A61KA61K31/198A61K31/205

Quick answer

US patent 9447406 (Chemically modified cystathionine beta-synthase enzyme for treatment of homocystinuria) held by The Regents of the University of Colorado, a Body Corporate expires Mon Sep 15 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of Colorado, a Body Corporate
Grant date
Tue Sep 20 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 15 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
17
CPC classes
A61K, A61K31/198, A61K31/205, A61K31/385, A61K38/51